Cancer Related News
Cervical Screening Wales extends routine screening to every five years
Cervical screening Wales is extending the routine screening interval for people with a cervix aged 25-49 from three to five years if Human papillomavirus...
Lack of evidence for dietary supplement use in cancer patients
New research has indicated that many individuals living with and beyond cancer take dietary supplement tablets, often with the belief that the products will...
Trial identifies five-drug combo for bone marrow cancer
A new trial found that a combination of five existing drugs fights against bone marrow cancer for longer in patients.
The five-drug cocktail, along with...
Blood sugar control is key to reducing cancer risk in obesity and type 2...
Blood sugar control is important for reducing cancer risk in obesity and type 2 diabetes. Significant weight loss appears to afford protection against cancer,...
Over 600 people in England to benefit from new lung cancer treatment
Osimertinib (Tagrisso) is a new lung cancer treatment that will be used for non-small cell lung cancer (NSCLC) that has begun to spread. It...
€1m grant awarded to enhance research for lymphoma treatment
A substantial €1m in funding has been presented to advance lymphoma treatment, a significant milestone toward developing an effective therapy for the form of...
Repurposed Alzheimer’s medication provides new glioblastoma treatment
Exciting new research has identified that a drug previously prescribed for Alzheimer's disease may work as an effective glioblastoma treatment.
An investigation conducted by Cleveland...
Fewer cases of children with cancer diagnosed during COVID-19 pandemic
A study showed that in England, fewer children and young adults with cancer were diagnosed during the COVID pandemic. It also revealed that children...
Exercise helps improve recovery for women after breast cancer surgery
Early post-operative exercise appears to help women recover better from breast cancer surgery when compared to receiving standard care only, a new study shows.
A...
Measuring the effectiveness of prostate cancer treatment using blood tests
Regular blood tests before and after chemotherapy could indicate whether a patient is responding to prostate cancer treatment, research presented at the National Cancer Research Institute Festival suggests.
Caitlin Davies, a PhD...
New brain tumour research shows link between survival and ethnicity
New brain tumour research by Kings College London, UK, has been presented at the National Cancer Research Institute festival, identifying a link between ethnicity...
Defence Therapeutics: Optimising drug efficacy with AccumTM technology
Health Europa is excited to introduce the latest captivating eBook from industry pioneers of the biotechnology sector, Defence Therapeutics, who comprehensively elucidate their revolutionary...
Pilot study finds advantages of whole genome sequencing for children with cancer
A study has found that whole genome sequencing can give a more accurate diagnosis or reveal new treatment options for children with cancer.
A pilot...
Pancreatic cancer immunotherapy enhanced by new experimental drug
A team of researchers has identified a novel experimental drug that effectively boosts the efficacy of pancreatic cancer immunotherapy, potentially a landmark breakthrough in...
AI breast cancer diagnosis technology approved for UK and EU
The world's first Artificial Intelligence (AI) software that can accurately perform breast cancer diagnosis has received approval for implementation in the UK and EU.
The...
Drug enhances bone marrow transplant outcomes for leukaemia patients
Experts have identified a drug that reduces the risk of leukaemia recurring when administered in combination with a bone marrow transplant.
A team of researchers...
BRCA2 gene investigation may help to design targeted cancer treatment
Danish researchers have potentially made a groundbreaking advancement in developing an effective targeted therapy for cancer, identifying the pivotal role that the BRCA2 gene...
AccumTM variants successfully increase breast cancer treatment potency
Biotechnology experts Defence Therapeutics have revealed strong in vitro results of its AccumTM variants on the ADC breast cancer treatment called Enhertu® (fam-trastuzumab-deruxtecan-nxki), which...
Improving outcomes for children following radiation therapy
A team of experts from around the world has teamed up to improve clinical outcomes for children with cancer following radiation therapy.
Radiation therapy has...
Analysis of enzyme could improve Alzheimer’s and cancer treatment
Advancement in treatment for Alzheimer's disease and cancer could be on the horizon thanks to a novel investigation of the meprin β enzyme.
Researchers from...